We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research 2005 September
BACKGROUND: The Seventh Report of the Joint National Committee (JNC-7) on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure provided a new classification of blood pressure for adults aged to guide screening and treatment efforts.
MATERIAL/METHODS: Using the new classification, we examined trends and prevalence of pre-hypertension (120-139/80-89 mm Hg), stage 1 hypertension (140-159/90-99 mm Hg), and stage 2 hypertension (> or = 160/100 mm Hg) in a nationally representative sample of the United States population. We analyzed 4115 adult persons from 1999 and 2000 National Health and Nutrition Examination Survey (NHANES), 20,322 persons from NHANES II (1976-1980) and 30,818 persons from NHANES III (1988-1992).
RESULTS: In the United States population aged 20 or greater, we found that an estimated 41.9 million men and 27.8 million women have pre-hypertension, 12.8 million men and 12.2 million women have stage 1 hypertension, and 4.1 million men and 6.9 million women have stage 2 hypertension. Age- and sex-adjusted rates of pre-hypertension increased among non-Hispanic White, African American, and Hispanic persons between 1988-1992 and 1999-2000. Age- and sex-adjusted rates of stage 1 hypertension increased among Hispanics between 1988-1992 and 1999-2000. Age- and sex-adjusted rates of stage 2 hypertension decreased among non-Hispanic Whites between 1988-1992 and 1999-2000, but were unchanged for African American and Hispanic persons.
CONCLUSIONS: With over a 100 million persons with pre-hypertension or hypertension in the United States, a renewed effort directed towards screening, education, and treatment is required, particularly in the Hispanic population.
MATERIAL/METHODS: Using the new classification, we examined trends and prevalence of pre-hypertension (120-139/80-89 mm Hg), stage 1 hypertension (140-159/90-99 mm Hg), and stage 2 hypertension (> or = 160/100 mm Hg) in a nationally representative sample of the United States population. We analyzed 4115 adult persons from 1999 and 2000 National Health and Nutrition Examination Survey (NHANES), 20,322 persons from NHANES II (1976-1980) and 30,818 persons from NHANES III (1988-1992).
RESULTS: In the United States population aged 20 or greater, we found that an estimated 41.9 million men and 27.8 million women have pre-hypertension, 12.8 million men and 12.2 million women have stage 1 hypertension, and 4.1 million men and 6.9 million women have stage 2 hypertension. Age- and sex-adjusted rates of pre-hypertension increased among non-Hispanic White, African American, and Hispanic persons between 1988-1992 and 1999-2000. Age- and sex-adjusted rates of stage 1 hypertension increased among Hispanics between 1988-1992 and 1999-2000. Age- and sex-adjusted rates of stage 2 hypertension decreased among non-Hispanic Whites between 1988-1992 and 1999-2000, but were unchanged for African American and Hispanic persons.
CONCLUSIONS: With over a 100 million persons with pre-hypertension or hypertension in the United States, a renewed effort directed towards screening, education, and treatment is required, particularly in the Hispanic population.
Full text links
Trending Papers
Acute and non-acute decompensation of liver cirrhosis (47/130).Liver International : Official Journal of the International Association for the Study of the Liver 2024 March 2
Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM).Clinical Infectious Diseases 2024 March 6
Ten Influential Point-of-Care Ultrasound Papers: 2023 in Review.Journal of Intensive Care Medicine 2024 Februrary 20
Administration of methylene blue in septic shock: pros and cons.Critical Care : the Official Journal of the Critical Care Forum 2024 Februrary 17
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app